
24QSCFA02 Quicksilver Questionnaire
This survey will take no longer than 10 minutes of your time to complete and is intended to assess your eligibility for this KGK Science clinical trial. This clinical trial will examine the efficacy and safety of an investigational product with and without the use of semaglutide on glycemic response in adults with prediabetes or Type 2 Diabetes. You do not have to answer all the questions if you do not feel comfortable doing so. However, we do need the answers to qualify you for the study.
60Questions